Showing results (161-170 of 305) with videos related to
Sort By:
Pageof 31
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2021
Urine Tenofovir Levels Measured Using a Novel Immunoassay Predict Human Immunodeficiency Virus ProtectionRandy M Stalter, Jared M Baeten, Deborah Donnell, et al.Stroke|September 30, 2006
Candidate gene polymorphisms do not differ between newborns with stroke and normal controlsSteven P Miller, Yvonne W Wu, Janet Lee, et al.Plos One|December 25, 2013
No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxisJulia L Marcus, David V Glidden, Kenneth H Mayer, et al.The Journal of Antimicrobial Chemotherapy|December 14, 2018
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistanceAnna Maria Geretti, Ellen White, Chloe Orkin, et al.Journal of Virus Eradication|November 23, 2019
Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIVOliver T Stirrup, Caroline A Sabin, Andrew N Phillips, et al.JAMA Ophthalmology|April 26, 2014
Early addition of topical corticosteroids in the treatment of bacterial keratitisKathryn J Ray, Muthiah Srinivasan, Jeena Mascarenhas, et al.AIDS (London, England)|May 11, 2002
Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapyAlexander J Frater, David T Dunn, Alison J Beardall, et al.Journal of Virology|December 15, 2005
Inactivation of prions by acidic sodium dodecyl sulfateDavid Peretz, Surachai Supattapone, Kurt Giles, et al.American Heart Journal|May 16, 2016
Impact of genetic variants on the upstream efficacy of renin-angiotensin system inhibitors for the prevention of atrial fibrillationJason D Roberts, Thomas A Dewland, David V Glidden, et al.Investigative Ophthalmology & Visual Science|February 7, 2013
Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitisCatherine E Oldenburg, Prajna Lalitha, Muthiah Srinivasan, et al.Pageof 31